Market Overview:
The global octreotide acetate market is expected to grow at a CAGR of 6.5% from 2018 to 2030. The growth in the market can be attributed to the increasing prevalence of acromegaly and neuroendocrine tumors, rising geriatric population, and growing demand for octreotide acetate in medical therapeutics and medical prophylactics. However, the high cost of treatment is expected to restrain the growth of this market during the forecast period. Based on type, the global octreotide acetate market is segmented into immediate-release injection form and LAR depot form. The LAR depot form segment is projected to grow at a higher CAGR than the immediate-release injection form segment during the forecast period. This can be attributed to its longer duration of action as compared with that of immediate-release injection forms. Based on application,the global octreotide acetate market is divided into medical therapeutics and medical prophylactics segments. The medical therapeutics segment accounted for a larger share of this market in 2017 owingto its widespread use for treating various diseases such as acromegalyand neuroendocrine tumors .
Product Definition:
Octreotide acetate is a synthetic hormone that is used to treat various conditions such as tumors of the pancreas, gastrointestinal tract, and lungs. It works by slowing down the growth of cancer cells.
Immediate-Release Injection Form:
Immediate-release injection form is used in the treatment of acromegaly, gigantism, and other related diseases. It is also used as a maintenance therapy for these conditions. The drug has gained wide acceptance globally due to its efficiency and safety profile when compared to traditional long-acting injectable drugs.
LAR Depot Form:
The International Society of Aesthetic Plastic Surgery (ISAPS) estimated the total number of non-surgical procedures carried out at around 6.3 million in 2015 and projected a growth rate of 7% from 2016 to 2024. The demand for non-invasive or minimally invasive procedures is increasing globally due to its several advantages such as reduced pain, cost efficiency, increased safety & efficacy, and shorter recovery time.
Application Insights:
Medical therapeutic application of octreotide acetate dominated the overall market in terms of revenue share in 2017. This is due to increasing use of the drug as a substitute for somatostatin Analogs, which are used for treating acromegaly and other pituitary disorders. The medical prophylactic segment is expected to witness lucrative growth over the forecast period owing to growing awareness about organ transplantation and rising incidences of diabetes mellitus type 2 across various regions.
Octreotide acetate injection has been approved by U.
Regional Analysis:
North America dominated the global market in 2017. The presence of a large number of manufacturers coupled with high R&D investment by companies is expected to result in maintaining dominance over the forecast period. In addition, increasing prevalence of diseases such as diabetes and cancer is anticipated to drive demand for octreotide acetate injections over the forecast period.
Asia Pacific region is expected to witness lucrative growth during the forecast period owing to rising disposable income, improving healthcare infrastructure and growing awareness about available treatment options among patients. Increasing incidence rate of gastric ulcers due to various factors such as stress, diet or alcohol consumption has been observed in this region has also led medical practitioners towards using prophylaxis drugs rather than treating ulcers once they occur (Zhang et al., 2016). This factor along with growing geriatric population will further boost regional growth during the projected time frame.
In Latin America, Brazil accounted for a major share followed by Argentina which was valued at USD X million.
Growth Factors:
- Increasing incidence of acromegaly and neuroendocrine tumors
- Growing demand for long-acting octreotide formulations
- Rising awareness about the benefits of octreotide acetate therapy
- Technological advancements in the field of octreotide acetate research and development
- Increasing number of clinical studies evaluating the efficacy and safety of octreotide acetate
Scope Of The Report
Report Attributes
Report Details
Report Title
Octreotide Acetate Market Research Report
By Type
Immediate-Release Injection Form, LAR Depot Form
By Application
Medical Therapeutic, Medical Prophylactic
By Companies
Samarth Pharma, Critical Care, Sun Pharmaceutical Industries, Neiss Labs, Novartis, Unique Chemicals, Sandostatin, Xinyhuanshun, Aituo, Shengtian, Samarth Pharma
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
143
Number of Tables & Figures
101
Customization Available
Yes, the report can be customized as per your need.
Global Octreotide Acetate Market Report Segments:
The global Octreotide Acetate market is segmented on the basis of:
Types
Immediate-Release Injection Form, LAR Depot Form
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Medical Therapeutic, Medical Prophylactic
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Samarth Pharma
- Critical Care
- Sun Pharmaceutical Industries
- Neiss Labs
- Novartis
- Unique Chemicals
- Sandostatin
- Xinyhuanshun
- Aituo
- Shengtian
- Samarth Pharma
Highlights of The Octreotide Acetate Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Immediate-Release Injection Form
- LAR Depot Form
- By Application:
- Medical Therapeutic
- Medical Prophylactic
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Octreotide Acetate Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Octreotide acetate is a medication used to treat cancer. It works by stopping the growth of cancer cells.
Some of the major players in the octreotide acetate market are Samarth Pharma, Critical Care, Sun Pharmaceutical Industries, Neiss Labs, Novartis, Unique Chemicals, Sandostatin, Xinyhuanshun, Aituo, Shengtian, Samarth Pharma.
The octreotide acetate market is expected to register a CAGR of 6.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Octreotide Acetate Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Octreotide Acetate Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Octreotide Acetate Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Octreotide Acetate Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Octreotide Acetate Market Size & Forecast, 2020-2028
4.5.1 Octreotide Acetate Market Size and Y-o-Y Growth
4.5.2 Octreotide Acetate Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Immediate-Release Injection Form
5.2.2 LAR Depot Form
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Medical Therapeutic
6.2.2 Medical Prophylactic
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Octreotide Acetate Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Octreotide Acetate Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Immediate-Release Injection Form
9.6.2 LAR Depot Form
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Medical Therapeutic
9.10.2 Medical Prophylactic
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Immediate-Release Injection Form
10.6.2 LAR Depot Form
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Medical Therapeutic
10.10.2 Medical Prophylactic
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Immediate-Release Injection Form
11.6.2 LAR Depot Form
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Medical Therapeutic
11.10.2 Medical Prophylactic
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Immediate-Release Injection Form
12.6.2 LAR Depot Form
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Medical Therapeutic
12.10.2 Medical Prophylactic
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Immediate-Release Injection Form
13.6.2 LAR Depot Form
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Medical Therapeutic
13.10.2 Medical Prophylactic
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Octreotide Acetate Market: Competitive Dashboard
14.2 Global Octreotide Acetate Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Samarth Pharma
14.3.2 Critical Care
14.3.3 Sun Pharmaceutical Industries
14.3.4 Neiss Labs
14.3.5 Novartis
14.3.6 Unique Chemicals
14.3.7 Sandostatin
14.3.8 Xinyhuanshun
14.3.9 Aituo
14.3.10 Shengtian
14.3.11 Samarth Pharma
